Christian Bell is a Senior Director and Head of Business Development and Intellectual Property at Otsuka Medical Devices Co., Ltd. where he is responsible for the group’s strategic transactions, overseas subsidiaries and its global intellectual property operations. Since 2018, Christian has been a director of Veryan and Board Secretary of ReCor Medical Inc. Christian is also a Managing Director of Otsuka Medical Devices Europe GmbH, the groups European marketing and sales operations subsidiary. Prior to assuming his role at Otsuka Medical Devices, Christian was a senior member of Otsuka Holdings’ Business Development and Planning Department responsible for capital markets and strategic transactions, especially in the medical device sector.
Kazumichi Kobayashi, R.Ph., is an Executive Deputy President of Otsuka Medical Devices. Co., Ltd., and Advisor of Otsuka Holdings Co., Ltd. He was a Senior Vice President and Co-head of Otsuka Pharmaceutical Business Division, as well as head of Clinical Development, Regulatory Affairs, and Quality Assurance at Otsuka Pharmaceuticals Co, Ltd. Concurrently he served as CEO of Otsuka Maryland Research Institute and from 2007, as the first CEO of Otsuka Pharmaceutical Development and Commercialization Inc.
The BioMimics-3D Vascular Stent System has a unique 3D helical geometry which imparts a gentle helical shape to the stented artery.